[1]邵毅,吴康瑞,叶蕾.干眼的发病机制及治疗研究进展[J].眼科新进展,2020,40(4):301-306.[doi:10.13389/j.cnki.rao.2020.0070]
　SHAO Yi,WU Kangrui,YE Lei.Recent advance in dry eye pathogenesis and treatment[J].Recent Advances in Ophthalmology,2020,40(4):301-306.[doi:10.13389/j.cnki.rao.2020.0070]
点击复制

干眼的发病机制及治疗研究进展/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年4期
页码:
301-306
栏目:
述评
出版日期:
2020-04-05

文章信息/Info

Title:
Recent advance in dry eye pathogenesis and treatment
作者:
邵毅; 吴康瑞; 叶蕾
330006　江西省南昌市,南昌大学第一附属医院眼科
Author(s):
SHAO Yi; WU Kangrui; YE Lei
Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China
关键词:
干眼; 病因; 发病机制; 治疗
Keywords:
dry eye;  etiology;  pathogenesis;  treatment
分类号:
R777.34
DOI:
10.13389/j.cnki.rao.2020.0070
文献标志码:
A
摘要:
第二次国际干眼研讨会于2017年夏季报告提出，干眼是一种多因素的眼表疾病，其特征是泪膜稳态丧失，伴有眼部症状，其中泪膜不稳定和高渗透压、眼表炎症和损伤以及神经感觉异常具有致病作用。干眼是一个重要的公共卫生问题，会导致卫生成本增高，阻碍日常活动的开展，从而降低人群生活质量。本文简要介绍干眼的病因、发病机制，并着重介绍近2 a来关于干眼治疗的一些新进展。
Abstract:
A new definition of dry eye was proposed in the report of the Second International Dry Eye Symposium in the summer of 2017 that it is a multifactorial ocular surface disease characterized by loss of tear film homomorphism, accompanied by ocular symptoms, including tear film instability and high osmotic pressure, ocular surface inflammation and injury, and neurosensory abnormalities. Dry eye is an important public health problem, which will lead to higher health costs and hinder daily activities, thus reducing the quality of life. This article briefly introduces the etiology and pathogenesis of dry eye, and highlights some recent advances in the treatment of dry eye in the past two years.

参考文献/References:

［1］　DANIEL NELSON J D,CRAIG J P,AKPEK E K,AZAR D T,BELMONTE C,BRON A J,et al.TFOS DEWS II introduction［J］.Ocul Surf，2017,15:269-275.
［2］　SMITH J A.The epidemiology of dry eye disease:report of the Epidemiology Subcommittee of the International Dry Eye Workshop［J］.Ocul Surf,2007,5(2):93-107.
［3］　GEERLING G,BAUDOUIN C,ARAGONA P,ROLANDO M,BOBORIDIS K G,BENíTEZ-DEL-CASTILLO J M,et al.Emerging strategies for the diagnosis and treatment of meibomian gland dysfunction:proceedings of the ocean group meeting ［J］.Ocul Surf,2017,15(2)：179-192.
［4］　GEERLING G,TAUBER J,BAUDOUIN C,GOTO E,MATSUMOTO Y,O’BRIEN T,et al.The international workshop on meibomian gland dysfunction:report of the subcommittee on management and treatment of meibomian gland dysfunction［J］.Invest Ophthalmol Vis Sci,2011,52(4)：2050-2064.
［5］　FOULKS G N,LEMP M A.Report of 2007 the International Dry Eye Workshop (DEWS) Glossary［J］.Ocul Surf，2007,5(2):73-74.
［6］　ALBIETZ J M,SCHMID K L.Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction［J］.Clin Exp Optom，2017,100(6):603-615.
［7］　STEINHOFF M,SCHMELZ M,SCHAUBER J.Facial erythema of rosacea-aetiology,different pathophysiologies and treatment options［J］.Acta Derm Venereol,2016,96(5):579-586.
［8］　NEBBIOSO M,FAMELI V,GHARBIYA M,SACCHETTI M,ZICARI A M,LAMBIASE A.Investigational drugs for the treatment in dry eye disease［J］.Expert Opin Investig Drugs,2016,25(12):1437-1446.
［9］　SCHEIN O D,MUNOZ B,TIELSCH J M,TIELSCH K,BANDEEN-ROCHE S,WES T.Prevalence of dry eye among the elderly［J］.Am J Ophthalmol,1997,124(6):723-728.
［10］　王蕊,李岩,高建民,解士勇,亢雷,刘洋辰，等.干眼患者泪膜及睑板腺功能分析［J］.眼科新进展,2016，36(12):1145-1149.
WANG R,LI Y,GAO J M,XIE S Y,KANG L,LIU Y C,et al.Functional analysis of tear film and tarsal gland in dry eye patients ［J］.Rec Adv Ophthalmol,2016,36(12)：1145-1149.
［11］　马向芹.我国老年慢性病患者患病及用药状况研究［D］.开封：河南大学，2015.
MA X Q.Study on the prevalence and medication status of elderly patients with chronic diseases in China ［D］.Kaifeng:Henan Univerisity,2015.
［12］　WEI A,HONG J,SUN X,XU J.Evaluation of age-related changes in human palpebral conjunctiva and meibomian glands by in vivo confocal microscopy［J］.Cornea,2011,30(9):1007-1012.
［13］　MELLER D,TSENG S C.Conjunctivochalasis:Literature review and possible pathophysiology［J］.Surv Ophthalmol,1998,43(4):225-232.
［14］　DOGRU M,WAKAMATSU T,KOJIMAETAL T.The role of oxidative stress and inflammation in dry eye disease［J］.Cornea,2009,28(11):S70-S74.
［15］　林通,龚岚.性激素与干眼的相关性研究进展［J］.中华眼科杂志,2014,50(1)：65-68.
LIN T,GONG L.Research progress on the correlation between sex hormones and dry eye ［J］.Chin J Ophthalmol,2014,50 (1)：65-68.
［16］　SUZUKI T,RICHARDS S M,LIU S.Influence of sex on gene expression in human corneal epithelial cells［J］.Mol Vis,2009,15(271-274):2554-2569.
［17］　魏茜敏,邹文进.视频显示终端使用时间及睡眠时间对干眼患者泪液代谢的影响［J］.广东医学,2016,37(5):744-746.
WEI X M,ZOU W J.The effect of video display terminal use time and sleep time on tear metabolism in dry eye patients ［J］.Guangdong Med J,2016,37 (5):744-746.
［18］　胡春梅.白内障手术后干眼的临床分析［J］.世界最新医学信息文摘：电子版,2017,(39):9-10.
HU C M.Clinical analysis of dry eyes after cataract surgery ［J］.Abstra Lat Med Inform World (Electronic Version),2017,(39):9-10.
［19］　CALONGE M,LABETOULLE M,MESSMER E M,SHAH S,AKOVA Y A,BOBORIDIS K G,et al.Controlled adverse environment chambers in dry eye research［J］.Curr Eye Res,2018,43(4):445-450.
［20］　NEBBIOSO M,ZICARI A M,CELANI C,LOLLOBRIGI V,GRENG R,DUSE M.Pathogenesis of vernal keratoconjunctivitis and associated factors［J］.Semin Ophthalmol，2015,30:340-344.
［21］　DOHLMAN T H,JULIA D,REZA D,CHAUHAN S K.T cell-derived granulocyte-macrophage colony-stimulating factor contributes to dry eye disease pathogenesis by promoting CD11b+ myeloid cell maturation and migration［J］.Invest Ophthalmol Vis Sci,2017,58(2):1330-1336.
［22］　GEHLSEN U,BRAUN T,NOTARA M,KRSSER S,STEVEN P.A semifluorinated alkane (f4h5) as novel carrier for cyclosporine A:a promising therapeutic and prophylactic option for topical treatment of dry eye［J］.Graefes Arch Clin Exp Ophthalmol,2017,255(4):767-775.
［23］　ACAR D,IRENE T M M,MIGUEL G B,MANUEL G N,ROCO H V.Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment［J］.Contact Lens Anterior Eye,2017,41(1):93-96.
［24］　CHENG A M S,TIGHE S,SHEHA H,TSENG S C G.Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye disease［J］.Int Ophthalmol，2018,38(5):2219-2222.
［25］　ISOBEL M,KRISTINA S,ANDREAS B,GEREON P,STüHLER K,GERD G,et al.Evaluation of decellularized porcine jejunum as a matrix for lacrimal gland reconstruction in vitro for treatment of dry eye syndrome［J］.Invest Ophthalmol Vis Sci，2017，58(12):5564-5574.
［26］　BAUDOUIN C,FIGUEIREDO F C,MASSMER E M,ISMAIL D,AMRANE M,GARRIGUE J S,et al.A randomised study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye［J］.Eur J Ophthalmol,2017,27(5):520-530.
［27］　CHRISTOPHE B,SAINZ D L M,MOURAD A,JEAN-SBASTIEN G,DAHLIA I,FIGUEIREDO F C,et al.One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease［J］.Eur J Ophthalmol ,2017,27(6):678-685.
［28］　CHOI M G,YEO J H,KANG J W,CHUN Y S,LEE J K,KIM J C.Effects of botulinum toxin type a on the treatment of dry eye disease and tear cytokines ［J］.Graefes Arch Clin Exp,2019,257(2):331-338.
［29］　MOLINA-LEYVA I,MOLINA-LEYVA A,BUENO-CAVANILLAS A.Efficacy of nutritional supplementation with omega-3 and omega-6 fatty acids in dry eye syndrome:a systematic review of randomized clinical trials ［J］.Acta Ophthalmol,2017,95(8):e677-e685.
［30］　VANDERMEER G,CHAMY Y,PISELLA P J.Comparison of objective optical quality measured by double-pass aberrometry in patients with moderate dry eye:Normal saline vs.artificial tears:A pilot study ［J］.J Fr Ophthalmol,2018,41(2):e51-e57.
［31］　VILLATORO A J,FERNNDEZ V,CLAROS S,ALCOHOLADO C,CIFUENTES M,MERAYO-LLOVES J,et al.Regenerative therapies in dry eye disease:from growth factors to cell therapy［J］.Int J Mol Sci,2017,18(11):2264.
［32］　CHEN H C,CHEN Z Y,WANG T J,DREW V J,TSNEJ C L.Herbal supplement in a buffer for dry eye syndrome treatment［J］.Int J Mol Sci,2018,215:91-100.
［33］　CUI L,LEE H S,LI Y,CHOI J H,YOON K C.Experimental and clinical applications of chamaecyparis obtusa extracts in dry eye disease［J］.Oxid Med Cell Longev,2017(5):1-12.
［34］　KANG S W,KIM K A,LEE C H,YANG S J,KANG T K,JUNG J H,et al.A standardized extract of,rhynchosia volubilis,lour.Exerts a protective effect on benzalkonium chloride-induced mouse dry eye model［J］.J Ethnopharmacol,2018,215:9-100.
［35］　ALBIETZ J M,SCHMID K L.Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction［J］.Clin Exp Optom，2017,100(6):603-615.
［36］　SACHIKO I,MOTOKO K,RYUJI H,TOSHIHIRO I,YUSUKE I,SHIGERU N,et al.Clinical evaluation of a royal jelly supplementation for the restoration of dry eye:a prospective randomized double blind placebo controlled study and an experimental mouse model［J］.PLoS One,2017,12(1):e0169069.
［37］　KASETSUWAN N,SATITPITAKUL V,CHANGUL T,JARIYAKOSOL S.Incidence and pattern of dry eye after cataract surgery［J］.PLoS One,2013,8(11):e78657.
［38］　CHEN X,YUAN R,SUN M,CHEN X,CHEN C.Efficacy of an ocular bandage contact lens for the treatment of dry eye after phacoemulsification［J］.BMC Ophthalmol,2019,19(1):13.
［39］　MIYAKE G,OTA I,MIYAKE K,ZAKO M,IWAKI M.Effects of topical diquafosol pretreatment on intraoperative corneal wetting［J］.J Cataract Refract Surg,2014,40(10):1682-1688.
［40］　CUI L,LI Y,LEE H S,YANG J M,CHOI W,YOON K C.Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye［J］.Int Ophthalmol,2018,38(5):2021-2030.
［41］　RONALD MAURICIO S A,JESUS M L,MARIA LAURA F,LUISALBERTO R G,NANCY J,FRANCISCO M,et al.Plasma rich in growth factors for the treatment of dry eye after LASIK surgery［J］.Ophthalmic Res,2018,60(2):80-86.
［42］　GODIN M R,STINNETT S S,GUPTA P K.Outcomes of thermal pulsation treatment for dry eye syndrome in patients with sjogren disease［J］.Cornea,2018,37(9):1155-1158.
［43］　VANZINI M,GALLAMINI M.Amblyopia:can laser acupuncture be an option［J］.J Acupunct Meridian Study,2016,9(5):267-274.
［44］　GONG L,SUN X,CHAPIN W J.Clinical curative effect of acupuncture herapy on xerophthalmia［J］.Am J Chin Med,2010,38(4):651-659.
［45］　LEE J S,HWANG S H,SHIN B C,PARK Y M I,MOTOKO K,RYUJI H,et al.Electrical stimulation of auricular acupressure for dry eye:A randomized controlled-clinical trial［J］.Chin J Integr Med Nov,2017,23(11):822-828.
［46］　TSUBOTA K,YAMADA M,URAYAMA K.Spectacle side panels and moist inserts for the treatment of dry eye patients［J］.Cornea,1994,13:197-201.
［47］　OGAWA M,DOGRU M,TORIYAMA N,YAMAGUCHI T,SHIMAZAKI J,TSUBOTA K.Evaluation of the effect of moist chamber spectacles in patients with dry eye exposed to adverse environment conditions［J］.Eye Contact Lens,2018,44(6):379-383.
［48］　BUCKLEY J R.Assessment and management of dry eye disease［J］.Eye,2018,32:200-203.
［49］　NGO W,SRINIVASAN S,HOUTMAN D,JONES L.The relief of dry eye signs and symptoms using a combination of lubricants,lid hygiene and ocular nutraceuticals［J］.J Optom,2017,10(1):26-33.
［50］　KAWASHIMA M,UCHINO M,YOKO N,UCHINO Y,DOGRU M,KOMURO A,et al.The association between dry eye disease and physical activity as well as sedentary behavior:results from the Osaka Study［J］.J Ophthalmol,2014,2014:943786.
［51］　KAWASHIMA M,UCHINO M,YOKOI N,UCHINO Y,DOGRU M,KOMURO A,et al.Decreased tear volume in patients with metabolic syndrome:the osaka study［J］.Br J Ophthalmol,2014,98(3):418-420.
［52］　KAWASHIMA M,UCHINO M,YOKOI N,UCHINO Y,DOGRU M,KOMURO A,et al.Associations between subjective happiness and dry eye disease:a new perspective from the Osaka Study［J］.PLoS One,2015,10(4):e0123299.

相似文献/References:

[1]姜洋 李莹 王忠海 罗岩 金玉梅.小牛血去蛋白提取物眼用凝胶对LASIK 术后角膜修复及干眼的疗效观察[J].眼科新进展,2012,32(7):000.
[2]叶芬 王春红 陈银 施宇华 黄振平.人工泪液对糖尿病干眼患者泪河的影响[J].眼科新进展,2012,32(12):000.
[3]张磊 何彦津.无眼征Graves病患者的眼表损害[J].眼科新进展,2012,32(12):000.
[4]皮百木 穆红梅 张婉婷 郑娜 李娟.老年干眼患者眼表改变及其与睑板腺功能障碍的相关性[J].眼科新进展,2013,33(6):000.
[5]张宏 马俊旗 安晓 叶向彧.围绝经期干眼患者眼表CXCR3表达与性激素的相关性分析[J].眼科新进展,2013,33(9):000.
[6]叶芬 田农 施宇华 薛春燕 黄振平.糖尿病干眼患者的波前像差分析[J].眼科新进展,2012,32(4):000.
[7]魏瑞华 郝永娜 赵少贞.自身免疫相关性干眼动物模型的研究进展[J].眼科新进展,2012,32(7):000.
[8]魏瑞华 郝永娜 边领斋 李雪 粘红 赵少贞.Sjogren综合征相关性干眼发病机制的研究进展[J].眼科新进展,2013,33(3):000.
[9]邱伟强 李学民 王薇 刘子源 张志红.泪点栓塞和人工泪液对干眼患者视功能和泪膜稳定性的影响[J].眼科新进展,2013,33(10):000.
[10]毛祖红 王乐 邵毅 张广斌 叶向彧 陈乐磊 董诺.不同方位切口对角膜神经损伤及泪膜功能影响相关性研究[J].眼科新进展,2013,33(12):000.

备注/Memo

备注/Memo:
国家自然科学基金资助（编号：81660158、81460092、81400372）；江西省自然科学基金重大项目（编号：2016ACB21017）； 江西省青年科学基金（编号：20151BAB215016、20161BAB215198）；江西省重点研发项目（编号：20151BBG70223，20181BBG70004）; 江西省教育厅重点项目（编号：GJJ160020）; 江西省学位与研究生教育教学改革研究项目（编号：JXYJG-2018-013）；江西省基层卫生适宜技术“星火推广计划”项目（编号：20188003）；江西省卫计委科技计划面上项目（编号：20175116）；江西省卫计委中医药科技计划项目（编号：No:2018A060）
更新日期/Last Update: 2020-04-05